Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
levorphanol extended release (LevoCap ER) (formerly TQ-1020)
print preview
bookmark
share with colleague
General Information
Company
Relmada Therapeutics Inc.
Description
Once-daily, extended-release levorphanol in an abuse deterrent drug delivery system
Molecular Target
Mechanism of Action
Latest Stage of Development
IND
Indication
Pain
Partner
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy